Our vision and mission
Our vision is to reduce the global burden of pulmonary vascular disease (PVD) within the next two decades. We will achieve this through global collaboration, striving for excellence in clinical care, research and education in PVD.
Who we are
The Pulmonary Vascular Research Institute (PVRI) is a charity that brings the best medical professionals in the world together who have an interest in pulmonary hypertension or pulmonary vascular disease (PVD). PVD can be more commonly described as high blood pressure in the lungs. It is a fatal illness, often mis- or undiagnosed, that can affect people of all ages and socio-economic backgrounds, including many fit young athletes. It is estimated that over 70 million people in the world suffer from PVD, although this figure was recently challenged by several observations. An echocardiography study in a general population in central Europe estimated 2.6% pulmonary hypertension (PH) prevalence (Moreira et al, PLoS One 10(6): e0130072, 2015) among hospitalised patients in the US, the diagnosis of PH increased several fold over the past decades and the Heart of Soweto Study demonstrated that in the context of urban migration, air pollution and high prevalence of infections approximately 20% of all hospitalised patients present with some variant of PH. Current estimates suggest that PH is the 4th most common form of heart disease, affecting around 200 million people across the globe.
The PVRI is the only global medical society dedicated to pulmonary hypertension and pulmonary vascular diseases. All our efforts, as an organisation, are to improve the care of patients with PVD throughout the world by raising awareness of PVD, facilitating research and encouraging the development of medicines to treat PVD.
We have established Regional and Specialist Task Forces all over the world to raise awareness of the disease and to facilitate research.
The PVRI has established itself as the professional international organisation fighting PVD on a global scale. Our network has expanded to over 6,300 people spread across 103 different countries worldwide, including an active membership of 1,250 PH professionals. We are immensely proud of our international reach and global representation. The PVRI is the only organisation in this disease area with a truly global reach.
Industry: Our Roundtable members
Online educational content
Each year, we organise two large scientific meetings:
- The PVRI Annual World Congress on Pulmonary Vascular Disease, which always takes place at the end of January.
- The PVRI Drug Discovery & Development Symposium, which is held in June/July.
These events take place in different countries each year and are aimed at our members, the pharmaceutical industry and the drug regulatory bodies.
The scientific agenda includes conference talks, discussions, interviews and abstract presentations from our global network. The e-learning side of our site is populated by these lecture recordings and abstract submissions which allow us to educate all areas of the world that have access to the internet.
While our educational content is distributed online, our network of doctors and clinicians also help educate other professionals on the ground. Spanning over 103 different countries, our Task Forces specialise in eight different forms of the disease.
Our Task Forces include:
Disease and Speciality Task Forces
- Genetics & Molecular
- High Altitude
- Infection in Pulmonary Hypertension (this includes HIV, schistosomiasis)
- Innovative Drug Development Initiative
- Paediatric & Congenital Heart Disease
Regional Task Forces
- Central Asia Task Force
- China Task Force
- Eastern Mediterranean & Saudi Arabia Task Force (SAPH)
- Europe Task Force
- India Task Force
- North America Task Force
- South America Task Force
- South Africa & Sub-Saharan Africa Task Force
- South East Asia Task Force
The PVRI is proud to work with professional partner organisations around the world. PVRI members are, in many cases, members of one or more of these organisations and are encouraged to participate in scientific and social gatherings held during partner events. We emphasise the value that all levels of collaborative effort can bring in combating a disease of common focus. Listed here are details of organisations, which we collaborate with.